Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tubulis
Biotech
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Takeda taps longtime Lilly exec as US head. Biotech vet enters struggling Arena. Former Pfizer leader joins precocious biotech startup.
Darren Incorvaia
,
Zoey Becker
Sep 12, 2025 8:30am
J&J vet jumps to Affinia—Chutes & Ladders
Feb 7, 2025 8:30am
Gilead advances ADC dreams with potential $465M deal
Dec 3, 2024 10:54am
Introducing Fierce Biotech's 2024 Fierce 15
Aug 5, 2024 6:00am
Tubulis rides wave of ADC interest to $138M financing round
Mar 14, 2024 9:12am
Bristol Myers pays Tubulis $23M to develop solid tumor ADCs
Apr 20, 2023 5:00am
